Any current/future capex/capital investment/strategic investment?

GPT Healthcare is installing an orthopedic surgical robot at Howrah Hospital by the end of 2024 to enhance orthopedic services and improve patient volumes. The Dum Dum Hospital is expanding clinical capabilities with the commencement of full-fledged cardiothoracic surgeries and revamping offerings. A new oncology block is being added to the Agartala Hospital, with PET scan facilities operational and LINAC under commissioning; full operations expected by February 2025, targeting ~INR 20 crores annual revenue after maturity. The Raipur Hospital (160 beds) is expected to commence operations by Q4

Future growth expectations in sales/revenue/volumes?

GPT Healthcare expects revenue growth acceleration in the second half of FY25 after a flattish first half, impacted by local disturbances and natural calamities. The upcoming Raipur Hospital (160 beds), set to commence operations in Q4 FY25, is anticipated to contribute positively to revenues. Increased inpatient volumes noted: Salt Lake (+8.4%), Agartala (+11.8%), Howrah (+23%) quarter-on-quarter. Focus on reducing average length of stay (ALOS) improves patient throughput and ARPOB, supporting volume ramp-up. Expansion plans target a 1,000-bed hospital chain by 2027, enhancing overall scale a

Future growth expectations in earnings/operating earnings/profits/EPS?

Management aims to become a 1,000-bed hospital chain by 2027, indicating significant capacity expansion. Raipur hospital (160 beds) to commence operations by Q4 FY25, expected to break even around 15-16 months post-commissioning, adding positively to EBITDA. Oncology services at Agartala to be fully operational by Feb 2025, expected to generate ~INR 20 crores annually post-maturity. Focus on increasing ARPOB through short-stay departments, surgical robotics (orthopedics at Howrah), and expansion of cardiology and cardiothoracic services. Despite Q2 disruptions, management expects double-digit

Current/ Expected Orderbook/ Pending Orders?

The transcript and documents provided do not mention any details about the current or expected order book or pending orders for GPT Healthcare Limited. The discussion primarily focuses on operational performance, occupancy, capacity expansion, specialty focus, acquisitions, and financial metrics but does not include data on order books or pending orders.

GPT Healthcare LtdQ2 FY25Healthcare Services

GPT Healthcare Ltd Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹139P/E: 24.1Market Cap: ₹1.1K CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

GPT Healthcare expects revenue growth acceleration in the second half of FY25 after a flattish first half, impacted by local disturbances and natural calamities.
The upcoming Raipur Hospital (160 beds), set to commence operations in Q4 FY25, is anticipated to contribute positively to revenues.
Increased inpatient volumes noted: Salt Lake (+8.4%), Agartala (+11.8%), Howrah (+23%) quarter-on-quarter.
Focus on reducing average length of stay (ALOS) improves patient throughput and ARPOB, supporting volume ramp-up.
Expansion plans target a 1,000-bed hospital chain by 2027, enhancing overall scale and revenue.
Oncology service expansion in Agartala and cardiothoracic surgeries in Dum Dum expected to generate new revenue streams.
Installation of surgical robots (orthopedics in Howrah) aimed at attracting higher-end procedures, increasing ARPOB and revenues.
Management aims for a continuation of double-digit growth in second half FY25 and beyond.

Margin guidance

Category 3

Management aims to become a 1,000-bed hospital chain by 2027, indicating significant capacity expansion.
Raipur hospital (160 beds) to commence operations by Q4 FY25, expected to break even around 15-16 months post-commissioning, adding positively to EBITDA.
Oncology services at Agartala to be fully operational by Feb 2025, expected to generate ~INR 20 crores annually post-maturity.
Focus on increasing ARPOB through short-stay departments, surgical robotics (orthopedics at Howrah), and expansion of cardiology and cardiothoracic services.
Despite Q2 disruptions, management expects double-digit revenue growth in H2 FY25 fueled by volume ramp-up and new hospital commissioning.
EBITDA margin improvements noted, with an increase of 80 bps to 24.2% in Q2 FY25.
GOAL: Achieve 20% ROE and 25% ROCE for full fiscal year, indicating profitability growth focus.

See what GPT Healthcare Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

- There is no specific update on new acquisitions or inorganic expansion at this time; the company is evaluating opportunities but has not closed any deals yet. - No explicit mention of planned fundraising through debt or equity was made during the call. - Finance costs have decreased by 58% due to debt reduction, indicating efficient financial management and possibly no immediate need for new debt. - The company remains focused on organic growth, including commissioning new hospitals (e.g., Raipur in Q4 FY25) and clinical expansions rather than financing through new equity or debt as per the latest call details. - Any future fundraising plans have not been disclosed or indicated in the provided transcript. Overall, no current or near-term new fundraising through debt or equity was announced or discussed in this earnings call transcript.

See what GPT Healthcare Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

GPT Healthcare is installing an orthopedic surgical robot at Howrah Hospital by the end of 2024 to enhance orthopedic services and improve patient volumes.
The Dum Dum Hospital is expanding clinical capabilities with the commencement of full-fledged cardiothoracic surgeries and revamping offerings.
A new oncology block is being added to the Agartala Hospital, with PET scan facilities operational and LINAC under commissioning; full operations expected by February 2025, targeting ~INR 20 crores annual revenue after maturity.
The Raipur Hospital (160 beds) is expected to commence operations by Q4 FY25 (Feb-Mar 2025), aiming to break even EBITDA-wise within 15-16 months of commissioning.
Maintenance capex is steady at INR 8-10 crores annually.
Upgradation capex details were not specified but linked to introduction of superior clinical assets like surgical robots and oncology equipment.

Track GPT Healthcare Ltd — get its next earnings analysis in your feed

How does GPT Healthcare Ltd rank vs peers in Healthcare Services?

Pro feature

ThisGPT Healthcare Ltd

Rev 3Mar 3

See where GPT Healthcare Ltd sits in Healthcare ServicesSee which companies these are, and every other name in the sector.Open rankings

How does GPT Healthcare Ltd rank in Healthcare Services?

Compare GPT Healthcare Ltd against every Healthcare Services company (Q2 FY25) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

What GPT Healthcare Ltd's management said in earlier quarters

Others in Healthcare Services this season

Aatmaj Healthcare Ltd (Q1 FY27)
Revenue for Q1 FY 2026-27: ₹8.13 crore . Key investor presentation takeaways from Aatmaj Healthcare Ltd's Q1 FY27 investor presentation — and how it ranks again
Maitreya Medica. (Q2 FY26)
23.92 crore (Page 26). Key investor presentation takeaways from Maitreya Medica.'s Q2 FY26 investor presentation — and how it ranks against sector peers.
Metropolis Healt (Q2 FY26)
Organic growth remains strong at around 12%, with no immediate price hikes planned. Key concall takeaways from Metropolis Healt's Q2 FY26 earnings call — and…
Suven Life Scie. (Q4 FY26)
The provided pages of the investor presentation do not report any revenue, sales, or volume figures for the quarter. Key investor presentation takeaways from Su

Compare:vs Apollo Hospitals Enterprise Ltd vs Manipal Health Enterprises Ltd vs Max Healthcare Institute Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

GPT Healthcare Ltd Q2 FY25 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does GPT Healthcare Ltd rank in Healthcare Services?

Continue your research

What GPT Healthcare Ltd's management said in earlier quarters

Others in Healthcare Services this season